A Redox‐Triggered Polymeric Nanoparticle for Disrupting Redox Homeostasis and Enhanced Ferroptosis
Small · 2025
DOI: 10.1002/smll.202404299 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Yifei Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, 266073, China. Hauptthemen laut MEDLINE: Ferroptosis, Nanoparticles, Homeostasis, Polymers. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Youth Innovation Technology Project of Higher School in Shandong Province, Key Technology Research and Development Program of Shandong Province, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Cancer cells possess an efficient redox system, enabling them to withstand oxidative damage induced by treatments, especially in hypoxia areas and ferroptosis can disrupt redox homeostasis in cancer cell. Herein, GSH‐sensitive nanoparticles are constructed that induce ferroptosis by long‐lasting GSH depletion and enhanced PDT. Carbonic anhydrase IX inhibitor, protoporphyrin IX (Por) complexed with Fe and epirubicin (EPI) are grafted to hyaluronic acid (HA) via disulfide bonds to obtain HSPFE and loaded xCT inhibitor SAS for fabricating SAS@HSPFE which is actively targeted to deep hypoxic tumor cells, and explosively releasing EPI, Por‐Fe complex and SAS due to at high GSH concentration. Specifically, SAS inhibited the GSH biosynthesis, and the generation of ROS by Por and the involvement of Fe 2+ in the Fenton reaction jointly facilitates oxidative stress. Besides, Fe 2+ reacted with excess H 2 O 2 to produce O 2 , which continuously fuels PDT. GPX4 and SLC7A11 related to antioxidant defense are down‐regulated, while ACSL4 and TFRC promoting lipid peroxidation and ROS accumulation are up‐regulated, which enhanced ferroptosis by amplifying oxidative stress and suppressing antioxidant defense. SAS@HSPFE NPs revealed highly efficient antitumor effect in vivo study. This study provides a novel approach to cancer treatment by targeting redox imbalance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, 266073, China.
- Department of Recuperation Medicine, Qingdao Special Service Sanatorium of PLA Navy, Qingdao, 266071, China.
- Huaxi MR Research Center (HMRRC), Department of Radiology, West China Hospital, Sichuan University, Chengdu, 610041, China.
- National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, 610064, China.
- Department of Oral Implantology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, China.
ORCID-Profile: Yan Liang
Förderung
- Youth Innovation Technology Project of Higher School in Shandong Province
- Key Technology Research and Development Program of Shandong Province
- Natural Science Foundation of Shandong Province
Zitieren
APA
Li, Y., Han, S., Zhao, Y., Yan, J., Luo, K., Li, F., He, B., Sun, Y., Li, F., & Liang, Y. (2025). A Redox‐Triggered Polymeric Nanoparticle for Disrupting Redox Homeostasis and Enhanced Ferroptosis. Small. https://doi.org/10.1002/smll.202404299
Vancouver
Li Y, Han S, Zhao Y, Yan J, Luo K, Li F, et al. A Redox‐Triggered Polymeric Nanoparticle for Disrupting Redox Homeostasis and Enhanced Ferroptosis. Small. 2025. doi:10.1002/smll.202404299
BibTeX
@article{Li2025,
author = {Li, Yifei and Han, Shangcong and Zhao, Yi and Yan, Jianqin and Luo, Kui and Li, Fashun and He, Bin and Sun, Yong and Li, Fan and Liang, Yan},
title = {A Redox‐Triggered Polymeric Nanoparticle for Disrupting Redox Homeostasis and Enhanced Ferroptosis},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202404299}
}
EUVIMED